Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 7/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12730757 | 0.99 | TSHR (0.41) | TSHRTDP1ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL12730798 | 0.96 | TSHR (0.38) | TSHRTDP1ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL12730788 | 0.93 | NPC1 (0.38) | TSHRALDH1A1SMN1; SMN2KMT2AHTT | |
| SCHEMBL12730765 | 0.93 | NPC1 (0.38) | TSHRALDH1A1SMN1; SMN2KMT2AHTT | |
| SCHEMBL12730755 | 0.86 | HTT (0.38) | TDP1ALDH1A1SMN1; SMN2KMT2AHTT | |
| SCHEMBL12730820 | 0.86 | TSHR (0.34) | TSHRTDP1ALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL12730806 | 0.85 | HRH3 (0.37) | TDP1SMN1; SMN2KMT2AHTTHRH3 | |
| SCHEMBL12730824 | 0.84 | ELANE (0.33) | TSHRTDP1SMN1; SMN2KMT2AHTT | |
| SCHEMBL12730706 | 0.83 | HTT (0.42) | TDP1ALDH1A1SMN1; SMN2KMT2AHTT | |
| SCHEMBL12730787 | 0.81 | NPC1 (0.38) | TDP1ALDH1A1SMN1; SMN2KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404316-B2 | Polymerizable liquid crystal compound and its polymer | JNC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CCNT1, POF1B, CCND3 | TSHR 3371/4885TDP1 3038/4885ALDH1A1 926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.